Skip to Content

NAT 375 (Armodafinil 250 mg)

Pill with imprint NAT 375 is White, Elliptical / Oval and has been identified as Armodafinil 250 mg. It is supplied by Breckenridge Pharmaceutical, Inc..

Armodafinil is used in the treatment of narcolepsy; shift work sleep disorder; chronic fatigue syndrome; obstructive sleep apnea/hypopnea syndrome; adhd (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Armodafinil 250 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for NAT 375

Armodafinil

Imprint:
NAT 375
Strength:
250 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
CNS stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
4 - Some potential for abuse
Labeler / Supplier:
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC):
51991-0324

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide